ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1968

Pregnancy Outcomes in Idiopathic Inflammatory Myopathies: A Comparison to the General American Population

Ana Valle1, Melissa Fazzari2 and Shereen Mahmood3, 1Montefiore Medical Center, Bronx, NY, 2Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY, 3Albert Einstein College of Medicine / Montefiore Medical Center, New York, NY

Meeting: ACR Convergence 2023

Keywords: Myositis, pregnancy

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1945–1972) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Idiopathic inflammatory myopathies (IIM) are rare autoimmune conditions which cause multi-organ inflammation, particularly in the skin, lungs, and muscles. It is known that many autoimmune conditions affect a women’s ability to become pregnant and may lead to adverse pregnancy outcomes. Studying pregnancy within IIM has been difficult due to limited cases, yet there is increasing evidence that women with IIM have increased risk of pregnancy adverse outcomes, including pre-eclampsia and low birth weight. However, few studies have evaluated the spectrum of pregnancy outcomes in IIM or compared how these outcomes compare to the general population. Our aim was to evaluate the rate of term pregnancies, preterm pregnancies, abortions, and living children in women with a history of IIM and to compare these with a sample of American women.

Methods: The Montefiore Medical Center Myositis registry was created from patients that met 2017 EULAR/ACR classification criteria for IIM. Demographics, including age, race, ethnicity were documented. IIM subtype and date of diagnosis were also recorded. Patients who did not identify as female and lacked an obstetrics history recorded by a physician were excluded. Pregnancy outcomes, including number of term and preterm pregnancies, abortions, and living children were recorded. A preterm birth was defined as < 37 while term birth was considered >37 weeks. Abortions were further classified into elective, spontaneous, therapeutic, ectopic, or reason unknown. These same pregnancy outcomes were extracted from Section B of the CDC’s 2017-2019 National Survey of Family Group for comparison.

Results: Of 153 patients with IIM, 86 of them were female patients with an obstetrics history. The mean age of IIM diagnosis was 51.7 years old, and majority of women were of Latinx ethnicity (Table 1). There were a total number of 224 pregnancies; 185 were live births with 6 (3%) preterm births.The average number of live births was 2.13 per patient. There were 39 abortions, of which 17 (44%) were spontaneous, 12 (31%) were elective, 6 (15%) were therapeutic, 3 (8%) were ectopic and one was unknown. In comparison, the majority of women participated in the national survey were white and younger, with a mean of 32 years of age. The mean number of children was 1.2 per woman. The mean number of elective abortions were similar between the two groups (0.14 vs 0.152) and the mean number of spontaneous abortions was lower in women with a history of IIM in comparison to the general population (0.198 vs 0.306) (Table 1).

Conclusion: Female patients with a history of IIM did not confer higher frequencies of poor pregnancy outcomes, including spontaneous or elective abortions. Rate of preterm pregnancies were similar, if not lower, to national averages. Differences between our patient demographics and birth rates in comparison to the national sample may be due to cultural and socioeconomic factors. Lastly, our cohort was limited by its inability to differentiate pregnancy prior to or during active IIM disease.

Supporting image 1

Table 1. Comparison of demographics and pregnancy outcomes of women with a history of IIM and a sample of women in the general American population.


Disclosures: A. Valle: None; M. Fazzari: None; S. Mahmood: Qiagen, 6.

To cite this abstract in AMA style:

Valle A, Fazzari M, Mahmood S. Pregnancy Outcomes in Idiopathic Inflammatory Myopathies: A Comparison to the General American Population [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/pregnancy-outcomes-in-idiopathic-inflammatory-myopathies-a-comparison-to-the-general-american-population/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pregnancy-outcomes-in-idiopathic-inflammatory-myopathies-a-comparison-to-the-general-american-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology